echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Jiangxi Province suspended a number of unre assessed drugs hanging network involving Catopri tablets and other national varieties

    Jiangxi Province suspended a number of unre assessed drugs hanging network involving Catopri tablets and other national varieties

    • Last Update: 2020-11-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On September 9, 2020, Jiangxi Pharmaceutical Price and Purchasing Service Center issued a notice on the public adjustment of the online procurement qualification of drugs such as Ramifeding.
    In accordance with the Implementation Plan for the Central Procurement of Drugs in Public Hospitals in Jiangxi Province in 2015 and the Opinions of the General Office of the State Council on the Conduct of Consistent Evaluation of the Quality and Efficacy of Generic Drugs (State Office Issued No. 8 of 2016), the online procurement qualification of products that have been evaluated by consistency has been suspended for three other enterprises, and the procurement qualification shall be resumed after consistent evaluation.
    Specifically, most of them are shortlisted varieties from the third batch of countries, such as celexib capsules, catoply tablets, polypyride tablets, chlorovine flat tablets, cycloproxacin tablets hydrochloric acid, kramycin tablets, hydrochloride bromine tablets ... The notice said that after the enterprise application and verification, is now part of the drug online procurement qualification adjustment for publicity, the public notice period until September 14, 2020, if there is any objection, please on September 14 before 17:00, the seal of the unit materials submitted to Jiangxi Province pharmaceutical procurement service platform "drug bargaining procurement system - bargaining procurement entrance - business processing - complaint processing."
    attached: some of the drug online procurement qualification adjustment schedule
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.